Your guide to Ocrevus treatment for relapsing remitting MS (RRMS)

Emma, UK 

Living with MS since 2018 

On Ocrevus since 2018

Switched to Ocrevus SC in 2024

Amy, UK 

Living with MS since 2018 

On Ocrevus since 2021

Your guide to Ocrevus treatment for relapsing remitting MS (RRMS)

If you’re reading this, you have relapsing remitting MS (RRMS) and have been prescribed Ocrevus. This website aims to provide guidance on your MS treatment, Ocrevus.

As you’ll discover from the Helpful Resources page on this website, you’re part of a strong, supportive MS community, who are here to help.

"Ocrevus has minimal impact and disruption on your day-to-day life"

Emma 

Who has relapsing remitting MS (RRMS), on Ocrevus subcutaneous injection

Taking Ocrevus

Ocrevus is a medicine that can be administered to you in one of two different ways.

Find out more

FAQs

Find answers to commonly asked questions regarding treatment with Ocrevus.

Find out more

Helpful Resources

Other resources you might find useful.

Find out more

Reporting of side effects 

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Please report suspected side effects to the MHRA through the Yellow Card scheme, via the Yellow card website www.mhra.gov.uk/yellowcard, or the free Yellow Card app available in the Apple App Store or Google Play Store. You should also report side effects to Roche Products Ltd. by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.